Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 54.4 kDa. The protein migrates as 60-66 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Human Thrombopoietin R, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
The purity of Human Thrombopoietin R, His Tag (Cat. No. THR-H52H7) is more than 90% and the molecular weight of this protein is around 60-74 kDa verified by SEC-MALS.
Human Thrombopoietin R, His Tag (Cat. No. THR-H52H7) captured on CM5 Chip via anti-His antibody can bind Human Thrombopoietin, premium grade (Cat. No. THN-H5214) with an affinity constant of 2.32 nM as determined in SPR assay (Biacore T200) (QC tested).
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides innovative solutions for neuroscience research. Recombinant proteins, neural factors, pre-formed fibrils, electrophysiological electrodes, as well as Organoid Toolbox all in Aneuro aiming to advance neuroscience research, develop therapeutic interventions, and improve diagnostic methods for neurological diseases.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Fecha | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Recombinant human thrombopoietin biosimilar (Biolotus) | Approved | Biolotus | Zypotin-TPO | Brazil | Thrombocytopenia | Biolotus | 2015-01-01 | Thrombocytopenia | Details | |
Romiplostim | AMP-2; AMG-531 | Approved | Amgen Inc | Romiplate, Nplate | United States | Thrombocytopenia; Purpura, Thrombocytopenic, Idiopathic | Amgen Inc | 2008-08-22 | Bone Marrow Failure Disorders; Carcinoma, Non-Small-Cell Lung; Lymphoma; Lung Neoplasms; Lymphoma, Non-Hodgkin; Purpura, Thrombocytopenic; Thrombocytopenia; Acute Radiation Syndrome; Pancytopenia; Anemia, Aplastic; Solid tumours; Multiple Myeloma; Myelodysplastic Syndromes; Hodgkin Disease; Small Cell Lung Carcinoma; Neoplasms; Hematologic Neoplasms; Ovarian Neoplasms; Purpura, Thrombocytopenic, Idiopathic | Details |
Lusutrombopag | S-888711 | Approved | Shionogi & Co Ltd | Mulpleta | Japan | Thrombocytopenia | Shionogi & Co Ltd | 2015-09-28 | Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Thrombocytopenia | Details |
Herombopag Olamine | SHR-8735; SHR 8735 olamine | Approved | Jiangsu Hengrui Medicine Co Ltd | Hengqu, 恒曲 | Mainland China | Anemia, Aplastic; Thrombocytopenia | Jiangsu Hengrui Medicine Co Ltd | 2021-06-16 | Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Anemia, Aplastic; Breast Neoplasms; Thrombocytopenia; Carcinoma, Non-Small-Cell Lung | Details |
Recombinant human thrombopoietin mimetic-fusion protein (Qilu Pharmaceutical) | QL-0911 | Approved | Qilu Pharmaceutical Co Ltd | Mainland China | Thrombocytopenia | Qilu Pharmaceutical Co Ltd | 2024-04-02 | Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | Details | |
Eltrombopag Diolamine | SB-497115; SB-497115-GR; ETB-115 | Approved | Glaxosmithkline Plc | Revolade, Promacta/Revolade, 瑞弗兰, レボレード, Promacta | United States | Purpura, Thrombocytopenic, Idiopathic | Novartis Pharma Ag | 2008-11-20 | Hepatitis C; Hemorrhage; Liver Diseases; Leukemia, Megakaryoblastic, Acute; Blast Crisis; Bone Marrow Failure Disorders; Anemia, Aplastic; Hepatitis B; Leukemia, Basophilic, Acute; Osteosarcoma; Sarcoma; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Chronic-Phase; Thrombocytopenia; Leukemia, Myeloid, Acute; Leukemia, Monocytic, Acute; Hepatitis C, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Eosinophilic, Acute; Catheter-Related Infections; Purpura; Wiskott-Aldrich Syndrome; HIV Infections; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Bone marrow transplant rejection; Leukemia, Myeloid, Accelerated Phase; Hematopoietic stem cell transplantation (HSCT); Hematologic Neoplasms; Leukemia; Metabolic Dysfunction-Associated Steatotic Liver Disease; Purpura, Thrombocytopenic, Idiopathic; Blood Platelet Disorders; Myelodysplastic Syndromes; Liver Cirrhosis; Leukemia, Myelomonocytic, Acute; Neoplasms, Connective and Soft Tissue; Leukemia, Myelomonocytic, Chronic; Fanconi Anemia; Anemi | Details |
Avatrombopag Maleate | YM-477; AKR-501; AS-1670542; AKR-501-monomaleate; E-5501 | Approved | Astellas Pharma Inc | Doptelet, 苏可欣 | United States | Liver Diseases; Thrombocytopenia | Akarx Inc | 2018-05-21 | Purpura, Thrombocytopenic, Idiopathic; Drug-Related Side Effects and Adverse Reactions; Neoplasms; Blood Platelet Disorders; Liver Diseases; Cardiovascular Diseases; Thrombocytopenia; Lymphoma | Details |
Recombinant human thrombopoietin | rhTPO (3SBio) | Approved | Shenyang Sunshine Pharmaceutical Co Ltd | 特比奥, Tpiao, 特比澳 | Mainland China | Thrombocytopenia; Purpura, Thrombocytopenic, Idiopathic | Shenyang Sunshine Pharmaceutical Co Ltd | 2005-03-10 | Purpura, Thrombocytopenic, Idiopathic; Leukemia; Neutropenia; Plasmacytoma; Sepsis; Liver Cirrhosis; Multiple Myeloma; Liver Diseases; Breast Neoplasms; Thrombocytopenia; Lymphoma; Leukemia, Myeloid, Acute; Myelodysplastic-Myeloproliferative Diseases | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Romiplostim biosimilar (Enzene Biosciences) | 267639-76-9 | Phase 3 Clinical | Enzene Biosciences Ltd | Purpura, Thrombocytopenic, Idiopathic | Details |
Romiplostim biosimilar (Intas Pharmaceuticals) | Phase 3 Clinical | Intas Biopharmaceuticals | Purpura, Thrombocytopenic, Idiopathic | Details | |
Recombinant human thrombopoietin / thrombopoietin receptor agonist(Soochow University) | Phase 3 Clinical | The First Affiliated Hospital Of Soochow University | Delayed Graft Function | Details | |
Romiplostim biosimilar(Generium) | GNR-069 | Phase 3 Clinical | Cjsc Generium | Purpura, Thrombocytopenic, Idiopathic | Details |
Recombinant human thrombopoietin(Peking University People's Hospital) | Phase 2 Clinical | Peking University People'S Hospital | Purpura, Thrombocytopenic, Idiopathic | Details | |
Recombinant human thrombopoietin mimetics (Shandong Quangang) | Phase 2 Clinical | Shandong Quangang Pharmaceutical Co Ltd | Purpura, Thrombocytopenic, Idiopathic | Details | |
Recombinant human thrombopoietin (CPGJ) | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Thrombocytopenia | Details | |
Pegylated thrombopoietin mimetic peptide | SF-303; JNJ-26366821; RWJ-800088; PEG-TPOm | Phase 1 Clinical | Johnson & Johnson | Details | |
Romiplostim biosimilar(Geropharma) | GP-40141 | Phase 1 Clinical | Geropharm | Purpura, Thrombocytopenic, Idiopathic | Details |
SCB-219 | SCB-219-M; SCB-219; SCB-219M | Phase 1 Clinical | Sichuan Sanyecao Bio-Pharmaceutical Co Ltd | Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | Details |
Recombinant human thrombopoietin mimetic peptide-Fc fusion protein (Beijing Tide Pharmaceutical) | Phase 1 Clinical | Beijing Tide Pharmaceutical Co Ltd | Thrombocytopenia | Details | |
PEGylated thrombopoietin (Chongqing Paijin Bio) | Phase 1 Clinical | Chongqing Paijin Biotechnology Co Ltd | Thrombocytopenia | Details | |
Thrombopoietin agonist (Scripps Research) | 3D9 | Clinical | The Scripps Research Institute Inc | Thrombocytopenia | Details |
This web search service is supported by Google Inc.